Key Takeaways
- • Galen Weston Jr. committed an additional $180 million to venture capital through Wittington Ventures, his family holding company's private capital arm, launching the firm's third VC fund focused on Series A and Series B rounds.
- • Wittington Ventures has now deployed $820 million across five private capital funds since its launch seven years ago, with $400 million allocated to venture capital investments across three funds targeting U.S. and Canadian markets.
- • The new fund will concentrate investments in commerce, healthcare, consumer, climate, and food sectors aligned with the Weston family's commercial and philanthropic interests, according to Jim Orlando, managing partner of Wittington Ventures.
- • Wittington's $100-million early-stage fund has already backed two companies, including Toronto-based Grey Matter Neurosciences (focused on Alzheimer's treatment via focused ultrasound) and Vancouver-based ViewsML Technologies, which raised $4.9 million in seed funding in April 2025.
- • The capital commitment underscores the Weston family's strategic pivot toward venture-stage investing while maintaining control of George Weston Ltd. and Loblaw Companies Ltd., Canada's largest food retailer.
Summary
Billionaire Galen Weston Jr. expanded his venture capital footprint on September 10 with the launch of a $180-million fund through Wittington Ventures, the private capital arm of his family holding company. This third venture capital fund represents a continuation of the Weston family's systematic expansion into early-stage equity investing, complementing their longstanding retail and consumer assets.
The fund will target Series A and Series B financing rounds—the first two institutional venture capital stages following seed-stage funding. Jim Orlando, managing partner of Wittington Ventures, specified that the fund's investment thesis centers on sectors historically relevant to Weston family interests: commerce, healthcare, consumer goods, climate technology, and food systems. This strategic focus reflects both the family's existing business footprint and philanthropic priorities.
Since its founding seven years prior, Wittington Ventures has committed $820 million across five private capital funds. Venture capital represents $400 million of this total, distributed across the newly announced $180-million fund and two predecessors deploying $100 million and $120 million respectively, predominantly in U.S. markets. The firm also operates a dedicated $100-million early-stage fund targeting Canadian research commercialization in healthcare and climate technology, a differentiated strategy that emphasizes domestic innovation capture.
Early validation of Wittington's thesis is evident in its portfolio. The early-stage fund backed Toronto-based Grey Matter Neurosciences, which develops Alzheimer's and neurological disorder treatments using focused ultrasound technology derived from Sunnybrook Research Institute research. The fund also led a $4.9-million seed round for Vancouver-based ViewsML Technologies in April 2025. These investments demonstrate the fund's ability to identify and support Canadian deep-tech companies at critical scaling inflection points.
Weston's expanded venture commitments reflect a deliberate strategy to leverage family capital across the venture ecosystem while maintaining operational control of George Weston Ltd. and Loblaw Companies Ltd., Canada's dominant food retail operator. The $180-million commitment signals confidence in Series A/B market dynamics and positions the Weston family among Canada's most active family office venture investors.
The fund will target Series A and Series B financing rounds—the first two institutional venture capital stages following seed-stage funding. Jim Orlando, managing partner of Wittington Ventures, specified that the fund's investment thesis centers on sectors historically relevant to Weston family interests: commerce, healthcare, consumer goods, climate technology, and food systems. This strategic focus reflects both the family's existing business footprint and philanthropic priorities.
Since its founding seven years prior, Wittington Ventures has committed $820 million across five private capital funds. Venture capital represents $400 million of this total, distributed across the newly announced $180-million fund and two predecessors deploying $100 million and $120 million respectively, predominantly in U.S. markets. The firm also operates a dedicated $100-million early-stage fund targeting Canadian research commercialization in healthcare and climate technology, a differentiated strategy that emphasizes domestic innovation capture.
Early validation of Wittington's thesis is evident in its portfolio. The early-stage fund backed Toronto-based Grey Matter Neurosciences, which develops Alzheimer's and neurological disorder treatments using focused ultrasound technology derived from Sunnybrook Research Institute research. The fund also led a $4.9-million seed round for Vancouver-based ViewsML Technologies in April 2025. These investments demonstrate the fund's ability to identify and support Canadian deep-tech companies at critical scaling inflection points.
Weston's expanded venture commitments reflect a deliberate strategy to leverage family capital across the venture ecosystem while maintaining operational control of George Weston Ltd. and Loblaw Companies Ltd., Canada's dominant food retail operator. The $180-million commitment signals confidence in Series A/B market dynamics and positions the Weston family among Canada's most active family office venture investors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.